Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Six-week, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center, Phase II Study

This study has been completed.
Information provided by:
BioLineRx, Ltd. Identifier:
First received: December 4, 2007
Last updated: June 27, 2010
Last verified: June 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2009
  Primary Completion Date: July 2009 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):